- Home
- ELBM vs CODX Comparison
ELBM vs CODX Comparison
Compare ELBM & CODX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ELBM
- CODX
- Stock Information
- Founded
- ELBM 2011
- CODX 2013
- Country
- ELBM Canada
- CODX United States
- Employees
- ELBM N/A
- CODX N/A
- Industry
- ELBM Industrial Machinery/Components
- CODX Medical/Dental Instruments
- Sector
- ELBM Miscellaneous
- CODX Health Care
- Exchange
- ELBM Nasdaq
- CODX Nasdaq
- Market Cap
- ELBM 22.8M
- CODX 22.0M
- IPO Year
- ELBM N/A
- CODX 2017
- Fundamental
- Price
- ELBM $1.46
- CODX $0.48
- Analyst Decision
- ELBM Strong Buy
- CODX Hold
- Analyst Count
- ELBM 1
- CODX 1
- Target Price
- ELBM $5.20
- CODX $1.50
- AVG Volume (30 Days)
- ELBM 30.1K
- CODX 199.0K
- Earning Date
- ELBM 11-15-2024
- CODX 05-08-2025
- Dividend Yield
- ELBM N/A
- CODX N/A
- EPS Growth
- ELBM N/A
- CODX N/A
- EPS
- ELBM N/A
- CODX N/A
- Revenue
- ELBM N/A
- CODX $7,321,012.00
- Revenue This Year
- ELBM N/A
- CODX N/A
- Revenue Next Year
- ELBM $1,630.56
- CODX N/A
- P/E Ratio
- ELBM N/A
- CODX N/A
- Revenue Growth
- ELBM N/A
- CODX 57.16
- 52 Week Low
- ELBM $1.04
- CODX $0.46
- 52 Week High
- ELBM $2.83
- CODX $2.23
- Technical
- Relative Strength Index (RSI)
- ELBM 42.67
- CODX 33.37
- Support Level
- ELBM $1.52
- CODX $0.46
- Resistance Level
- ELBM $1.72
- CODX $0.68
- Average True Range (ATR)
- ELBM 0.13
- CODX 0.07
- MACD
- ELBM -0.02
- CODX -0.00
- Stochastic Oscillator
- ELBM 24.00
- CODX 16.75
About ELBM Electra Battery Materials Corporation
Electra Battery Materials Corp is building North America's fully integrated, localized, and environmentally sustainable battery materials park. Electra Battery Materials is an integral part of the North American battery supply chain, providing low-carbon, sustainable, and traceable raw materials for the region's fast growing electric vehicle industry.
About CODX Co-Diagnostics Inc.
Co-Diagnostics Inc is a molecular diagnostics company. It develops, licenses, and commercializes molecular technologies such as lab systems (MDx device) and manufacture and sell reagents used for tests that are designed using the detection and/or analysis of nucleic acid molecules (DNA or RNA). CDI's low-cost system uses its tests to diagnose tuberculosis, Zika, hepatitis B and C, Malaria, dengue and HIV.The Company's technologies are utilized for tests that are designed using the detection and/or analysis of nucleic acid molecules (DNA or RNA). The Company also uses its proprietary technology to design specific tests for its Co-Dx PCR platform and to locate genetic markers for use in applications other than infectious diseases.